KRT17 and cancer: Since 2004, 56 studies investigated the prognostic significance of K17 in human cancers, and of those, 32 (57.1%) studies assessed K17 expression at the protein level, 18 (32.1%) at the RNA level, and 6 (8.9%) at the RNA and protein level (Table 2, Figure 3).